Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.
- DOI
- 10.1016/j.toxrep.2020.12.013
- Published
- 2021
- Container
- Toxicology reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 27/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.toxrep.2020.12.013,
title = {Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.},
author = {Alexandris N and Lagoumintzis G and Chasapis CT and Leonidas DD and Papadopoulos GE and Tzartos SJ and Tsatsakis A and Eliopoulos E and Poulas K and Farsalinos K},
year = {2021},
journal = {Toxicology reports},
doi = {10.1016/j.toxrep.2020.12.013},
url = {https://doi.org/10.1016/j.toxrep.2020.12.013}
}RIS
TY - JOUR TI - Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. AU - Alexandris N AU - Lagoumintzis G AU - Chasapis CT AU - Leonidas DD AU - Papadopoulos GE AU - Tzartos SJ AU - Tsatsakis A AU - Eliopoulos E AU - Poulas K AU - Farsalinos K PY - 2021 JO - Toxicology reports DO - 10.1016/j.toxrep.2020.12.013 UR - https://doi.org/10.1016/j.toxrep.2020.12.013 ER -
APA
N, A., G, L., CT, C., DD, L., GE, P., SJ, T., A, T., E, E., K, P., & K, F. (2021). Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.. Toxicology reports. https://doi.org/10.1016/j.toxrep.2020.12.013
Source records
- pubmed · retrieved 2026-09-25T05:19:54.187Z